CervoMed

CervoMed Dividend Coverage

Dividend Coverage Ratio of CervoMed (CRVO) as of Oct 18, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of CervoMed is 2026 - . Dividend Coverage Ratio of CervoMed was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CervoMed Stock analysis

What does CervoMed do? CervoMed Inc., headquartered in Boston, Massachusetts, is a clinical-stage biotechnology company operating in the Health Care sector. The company focuses on developing CNS-targeted therapeutics for degenerative brain diseases, with its lead candidate neflamapimod in Phase IIb trials for dementia with Lewy Bodies, early Alzheimer’s, and stroke recovery. Employing 13 full-time staff, CervoMed was formerly known as Diffusion Pharmaceuticals Inc. and went public on 9 November 2016. CervoMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CervoMed stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio CervoMed since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's CervoMed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — CervoMed

All Key Metrics — CervoMed